Staging systems for follicular thyroid carcinoma: Application to 171 consecutive patients treated in a tertiary referral centre

Endocrine-Related Cancer

Volumn 14, Issue 1, 2007, Pages 29-42

  Lang, Brian Hung Hin ^a   Lo, Chung Yau ^a   Chan, Wai Fan ^a   Lam, King Yin ^b   Wan, Koon Yat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; REVIEW; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; CARCINOMA; METHODOLOGY; PATHOLOGY; THYROID TUMOR; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; CARCINOMA; HUMANS; NEOPLASM STAGING; THYROID NEOPLASMS;

EID: 34249781422     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01284     Document Type: Review

References (53)

1. Akslen LA 1993 Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72 2680-2685.
2. Baloch ZW & Livolsi VA 2002 Pathology of the thyroid gland. In Endocrine Pathology, pp 61-88. Eds VA Livolsi & SL Asa. New York: Churchill Livingstone.
3. Barbet J, Campion L, Kraeber-Bodere F, Chatal JF & GTE Study Group 2005 Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling times in patients with medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 90 6077-6084.
4. Beeken S, Roye D, Weiss H, Sellers M, Urist M & Diethelm A 2000 Extent of surgery for intermediate-risk well-differentiated thyroid cancer. American Journal of Surgery 179 51-56.
5. Besic N, Zgajnar J, Hocevar M & Frkovic-Grazio S 2005 Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 15 439-448.
6. Boulos DL, Groome PA, Brundage MD, Siemens DR, Mackillop WJ, Meaton JP, Schulze KM & Rohland SL 2006 Predictive validity of five comorbidity indices in prostate carcinoma patients with curative intent. Cancer 106 1804-1814.
7. Brennan MD, Bergstralh EJ, van Heerden JA & McConahey WM 1991 Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, and outcome. Mayo Clinic Proceedings 66 11-22.
8. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK & O'Sullivan B 1997 A comparison of different staging systems, predictability of patient outcome. Thyroid carcinoma as an example. Cancer 79 2414-2423.
9. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ & van Glabbeke M 1979 A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. European Journal of Cancer 15 1033-1041.
10. Cady B & Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 947-953.
11. Chaplin JM, O'Brien CJ, McNeil EB & Haghighi K 1999 Application of prognostic scoring systems in differentiated thyroid carcinoma. Australian and New Zealand Journal of Surgery 69 625-628.
12. Chow SM, Law SC, Au SK, Leung TW, Chan PT, Mendenhall WM & Lau WH 2002 Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head and Neck 24 670-677.
13. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Sherman SI & Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid carcinoma. Thyroid 16 109-142.
14. D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE & Clark OH 2004a Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 14 453-458.
15. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY & Clark OH 2004b Follicular thyroid carcinoma: histology and prognosis. Cancer 15 1123-1129.
16. Davies L & Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 295 2164-2167.
17. Davis NL, Bugis SP, McGregor GI & Germann E 1995 An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. American Journal of Surgery 170 476-480.
18. DeGroot LJ, Kaplan EL, McCormick M & Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 71 414-424.
19. DeGroot LJ, Kaplan EL, Shukla MS, Salti G & Straus FH 1995 Morbidity and mortality in follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism 80 2946-2953.
20. DeLellis RA, Lloyd RV, Heitz PU & Eng C 2004 World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. France: IARC (International Agency for Research on Cancer) Press.
21. Greene FL 2005 Cancer staging, prognostic factors, and our surgical challenges. American Surgeon 71 615-620.
22. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG & Morrow M 2002 AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6. New York: Springer-Verlag, Inc.
23. Hay ID, Grant CS, Taylor WF & McConahey WM 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102 1088-1095.
24. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR & Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 1050-1058.
25. Hedginer CE, Williams ED & Sobin LH 1988 In Histological Typing of Thyroid Tumours, International Histological Classification of Tumors, vol 11, pp 7-68. Ed CE Hedginer., Berlin: Springer-Verlag.
26. Holzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK & Hundahl SA 2000 Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer 89 192-201.
27. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK & Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer 89 202-217.
28. Jukkola A, Bloigu R, Ebeling T & Salmela P 2004 Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocrine-Related Cancer 11 571-579.
29. Kebebew E, Peng M, Reiff E & McMillan A 2006 Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 106 2592-2597.
30. Kjellman P, Zedenius J, Lundell G, Backdahl M, Farnebo LO, Hambeger B, Larsson C & Wallin G 2006 Predictors of outcome in patients with papillary thyroid carcinoma. European Journal of Surgical Oncology 32 345-352.
31. Lang BH, Lo CY, Chan WF, Lam KY & Wan KY 2006 Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathological features and long-term outcome. World Journal of Surgery 30 752-758.
32. Lang BH, Lo CY, Chan WF, Lam KY & Wan KY 2007a Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Annals of Surgical Oncology (In Press).
33. Lang BH, Lo CY, Chan WF, Lam KY & Wan KY 2007b Restaging of differentiated thyroid carcinoma by the 6th edition AJCC/UICC TNM staging system: stage migration and predictability. Annals of Surgical Oncology (In Press).
34. Lerch H, Schober O, Kuwert T & Saur HB 1997 Survival of differentiated thyroid carcinoma studied in 500 patients. Journal of Clinical Oncology 15 2067-2075.
35. Lo CY, Chan WF, Lam KY & Wan KY 2004 Optimizing the treatment of AMES high-risk papillary thyroid carcinoma. World Journal of Surgery 28 1103-1109.
36. Lo CY, Chan WF, Kam KY & Wan KY 2005 Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Annals of Surgery 242 708-715.
37. Lundgren CI, Hall P, Dickman PW & Zedenius J 2006 Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106 524-531.
38. Machens A, Holzhausen HJ & Dralle H 2005 The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103 2269-2273.
39. Mazzaferri EL & Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine 97 418-428.
40. Noguchi S, Murakami N & Kawamoto H 1994 Classification of papillary cancer of the thyroid based on prognosis. World Journal of Surgery 18 552-558.
41. Ortiz Sebastian S, Rodriguez Gonzalez JM, Parilla Paricio P, Sola Perez J, Perez Flores D, Pinero Madrona A, Ramirez Romero P & Tebar FJ 2000 Papillary thyroid carcinoma. Prognostic index for survival including the histological variety. Archives of Surgery 135 272-277.
42. Pasieka JL, Zedenius J, Auer G Gremelius L, Hoog A, Lundell G, Wallin G & Backdahl M 1992 Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid carcinoma. Surgery 112 1154-1160.
43. Passler C, Prager G, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zettinig G & Niederle B 2003 Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Annals of Surgery 207 227-234.
44. Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zettinig G & Niederle B 2004 Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocrine-Related Cancer 11 131-139.
45. Rosai J, Carcangiu ML & DeLellis RA 1992 Tumours of the thyroid gland. In Atlas of Tumour Pathology, 3rd series, fascicle 5, pp 49-63. Eds J Rosai & LH Sobin. Washington, DC: Armed Forces Institute of Pathology.
46. Schemper M & Stare J 1996 Explained variation in survival analysis. Statistics in Medicine 15 1999-2012.
47. Shaha AR 2004 Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 114 393-402.
48. Shaha AR, Loree TR & Shah JP 1994 Intermediate-risk group for differentiated carcinoma of the thyroid. Surgery 116 1036-1041.
49. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW et al. 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 83 1012-1021.
50. Steinmuller T, Klupp J, Rayes N, Ulrich F, Jonas S, Graf KJ & Neuhaus P 2000 Prognostic factors in patients with differentiated thyroid carcinoma. European Journal of Surgery 166 29-33.
51. Sugitani I, Kasai N, Fujimoto Y & Yanagisawa A 2004 A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135 139-148.
52. Wittekind CH, Greene FL, Henson DE, Hutter RVP & Sobin LH 2003 TNM Supplement: a Commentary on Uniform Use. edn 3. New York: Wiley-Liss, Inc.
53. Yildirim E 2005 A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. Journal of the American College of Surgeons 200 378-392.